Abstract
Protein phosphatase 2A (PP2A) consists of three subunits, A, B and C. The A and B subunits have regulatory functions while C is the catalytic subunit. PP2A core enzyme is composed of subunits A and C, and the holoenzyme of subunits A, B and C. All subunits exist as multiple isoforms or splice variants. The A subunit exists as two isoforms, Aα and Aβ. Here we report about the properties of eight Aβ mutants, which were found in human lung and colon cancer. These mutants were reconstructed by site-directed mutagenesis and assayed for their ability to bind B and C subunits. Two mutants showed decreased binding of PR72, a member of the B′′ family of B subunits, but normal C subunit binding; two mutants exhibited decreased binding of the C subunit and of B′′/PR72; and one mutant showed increased binding of both the C subunit andB′′/PR72. Of three mutants that behaved like the wild-type Aβ subunit, one is a polymorphic variant and another one is altered outside the binding region for B and C subunits. Importantly, we also found that the wild-type Aα and Aβ isoforms, although 85% identical, are remarkably different in their ability to bind B and C subunits. Our findings may have important implications in regard to the role of PP2A as a tumor suppressor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abraham D, Podar K, Pacher M, Kubicek M, Welzel N, Hemmings BA, Dilworth SM, Mischak H, Kolch W, Baccarini M . 2000 J. Biol. Chem. 275: 22300–22304
Andjelkovic N, Zolnierowicz S, Van Hoof C, Goris J, Hemmings BA . 1996 EMBO J. 15: 7156–7167
Bialojan C, Takai A . 1988 Biochem. J. 256: 283–290
Bosch M, Cayla X, Van Hoof C, Hemmings BA, Ozon R, Merlevede W, Goris J . 1995 Eur. J. Biochem. 230: 1037–1045
Brewis N, Ohst K, Fields K, Rapacciuolo A, Chou D, Bloor C, Dillmann W, Rockman H, Walter G . 2000 Am. J. Physiol. Heart Circ. Physiol. 279: H1307–H1318
Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini M . 2000 Oncogene 19: 1191–1195
Campbell IG, Manolitsas T . 1999 Oncogene 18: 6367–6369
Cegielska A, Shaffer S, Derua R, Goris J, Virshup DM . 1994 Mol. Cell. Biol. 14: 4616–4623
Chen S-C, Kramer G, Hardesty B . 1989 J. Biol. Chem. 264: 7267–7275
Cohen P, Cohen PTW . 1989 J. Biol. Chem. 264: 21435–21438
Csortos C, Zolnierowicz S, Bako E, Durbin SD, DePaoli-Roach AA . 1996 J. Biol. Chem. 271: 2578–2588
da Cruz e Silva OB, Alemany S, Campbell DG, Cohen PTW . 1987 FEBS Lett. 221: 415–422
Deng X, Ito T, Carr B, Mumby M, May Jr WS . 1998 J. Biol. Chem. 273: 34157–34163
Gayther SA, Barski P, Batley SJ, Li L, de Foy KA, Cohen SN, Ponder BA, Caldas C . 1997 Oncogene 15: 2119–2126
Goldberg Y . 1999 Biochem. Pharmacol. 57: 321–328
Götz J, Probst A, Ehler E, Hemmings B, Kues W . 1998 Proc. Natl. Acad. Sci. USA 95: 12370–12375
Green DD, Yang S.-I, Mumby MC . 1987 Proc. Natl. Acad. Sci. USA 84: 4880–4884
Groves MR, Hanlon N, Turowski P, Hemmings BA, Barford D . 1999 Cell 96: 99–110
Healy AM, Zolnierowicz S, Stapleton AE, Goebl M, DePaoli-Roach AA, Pringle JR . 1991 Mol. Cell. Biol. 11: 5767–5780
Hemmings BA, Adams-Pearson C, Maurer F, Muller P, Goris J, Merlevede W, Hofsteenge J, Stone SR . 1990 Biochemistry 29: 3166–3173
Hendrix P, Mayer-Jaekel RE, Cron P, Goris J, Hofsteenge J, Merlevede W, Hemmings BA . 1993 J Biol. Chem. 268: 15267–15276
Heriche JK, Lebrin F, Rabilloud T, Leroy D, Chambaz EM, Goldberg Y . 1997 Science 276: 952–955
Hong Y, Lubert EJ, Rodgers DW, Sarge KD . 2000 Biochem. Biophys. Res. Commun. 272: 84–89
Hsu W, Zeng L, Costantini F . 1999 J. Biol. Chem. 274: 3439–3445
Kamibayashi C, Estes R, Lickteig RL, Yang S, Craft C, Mumby MC . 1994 J. Biol. Chem. 269: 20139–20148
Kamibayashi C, Lickteig RL, Estes R, Walter G, Mumby MC . 1992 J. Biol. Chem. 267: 21864–21872
Kawabe T, Muslin AJ, Korsmeyer SJ . 1997 Nature 385: 454–458
Kitagawa Y, Tahira T, Ikeda I, Kikuchi K, Tsuiki S, Sugimura T, Nagao M . 1988 Biochim. Biophys. Acta. 951: 123–129
Kleinberger T, Shenk T . 1993 J. Virol. 67: 7556–7560
Kremmer E, Ohst K, Kiefer J, Brewis N, Walter G . 1997 Mol. Cell. Biol. 17: 1692–1701
Lebrin F, Bianchini L, Rabilloud T, Chambaz EM, Goldberg Y . 1999 Mol. Cell. Biochem. 191: 207–212
Li M, Makkinje A, Damuni Z . 1996 J. Biol. Chem. 271: 11059–11062
Marcellus RC, Chan H, Paquette D, Thirlwell S, Boivin D, Branton PE . 2000 J. Virol. 74: 7869–7877
Mayer RE, Hendrix P, Cron P, Matthies R, Stone SR, Goris J, Merlevede W, Hofsteenge J, Hemmings BA . 1991 Biochemistry 30: 3589–3597
McCright B, Rivers AM, Audlin S, Virshup DM . 1996 J. Biol. Chem. 271: 22081–22089
McCright B, Virshup DM . 1995 J. Biol. Chem. 270: 26123–26128
Mumby M . 1995 Sem. Cancer Biol. 6: 229–237
Mumby MC, Walter G . 1993 Physiol. Rev. 73: 673–699
Nagase T, Murakami T, Nozaki H, Inoue R, Nishito Y, Tanabe O, Usui H, Takeda M . 1997 J. Biochem. Tokyo 122: 178–187
Pallas DC, Weller W, Jaspers S, Miller TB, Lane WS, Roberts TM . 1992 J. Virol. 66: 886–893
Ruediger R, Brewis N, Ohst K, Walter G . 1997 Virology 238: 432–443
Ruediger R, Fields K, Walter G . 1999 J. Virol. 73: 839–842
Ruediger R, Hentz M, Fait J, Mumby M, Walter G . 1994 J. Virol. 68: 123–129
Ruediger R, Pham HT, Walter G . 2001 Oncogene 20: 10–15
Ruediger R, Roeckel D, Fait J, Bergqvist A, Magnusson G, Walter G . 1992 Mol. Cell. Biol. 12: 4872–4882
Ruediger R, van Wart Hood JE, Mumby M, Walter G . 1991 Mol. Cell. Biol. 11: 4282–4285
Santoro MF, Annand RR, Robertson MM, Peng Y, Brady MJ, Mankovich JA, Hackett MC, Ghayur T, Walter G, Wong WW, Giegel DA . 1998 J. Biol. Chem. 273: 13119–13128
Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM . 1999 Science 283: 2089–2091
Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T . 1999 Proc. Natl. Acad. Sci. USA 96: 10080–10085
Shtrichman R, Sharf R, Kleinberger T . 2000 Oncogene 19: 3757–3765
Stone SR, Hofsteenge J, Hemmings BA . 1987 Biochemistry 26: 7215–7220
Strack S, Chang D, Zaucha JA, Colbran RJ, Wadzinski BE . 1999 FEBS Lett. 460: 462–466
Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ohika M, Wakamatsu K, Yamada K, Sugimura T . 1988 Proc. Natl. Acad. Sci. USA 85: 1768–1771
Takagi Y, Futamura M, Yamaguchi K, Aoki S, Takahashi T, Saji S . 2000 Gut 47: 268–271
Tanabe O, Nagase T, Murakami T, Nozaki H, Usui H, Nishito Y, Hayashi H, Kagamiyama H, Takeda M . 1996 FEBS Lett. 379: 107–111
Tehrani MA, Mumby MC, Kamibayashi C . 1996 J. Biol. Chem. 271: 5164–5170
Virshup DM . 2000 Curr. Opin. Cell Biol. 12: 180–185
Voorhoeve PM, Hijmans EM, Bernards R . 1999 Oncogene 18: 515–524
Walter G, Ferre F, Espiritu O, Carbone-Wiley A . 1989 Proc. Natl. Acad. Sci. USA 86: 8669–8672
Walter G, Mumby M. . 1993 Biochim. Biophys. Acta 1155: 207–226
Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J, Evans GA . 1998 Science 282: 284–287
Westphal RS, Anderson KA, Means AR, Wadzinski BE . 1998 Science 280: 1258–1261
Westphal RS, Coffee Jr RL, Marotta A, Pelech SL, Wadzinski BE . 1999 J. Biol. Chem. 274: 687–692
Yan Z, Fedorov SA, Mumby MC, Williams RS . 2000 Mol. Cell. Biol. 20: 1021–1029
Zolnierowicz S, Csortos C, Bondor J, Verin A, Mumby MC, DePaoli-Roach AA . 1994 Biochemistry 33: 11858–11867
Acknowledgements
We thank Glen Evans for the Aβ cDNA plasmid, Marc Mumby for the Bα and B′α1 cDNA plasmids, and Brian Hemmings for the B′′/PR72 cDNA plasmid. We also acknowledge the UCSD Cancer Center Sequencing Facility. This work was supported by the Tobacco-Related Diseases Research Program, grant 8RT-0037, and Public Health Service grant CA-36111.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruediger, R., Pham, H. & Walter, G. Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the Aβ subunit gene. Oncogene 20, 1892–1899 (2001). https://doi.org/10.1038/sj.onc.1204279
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204279
Keywords
This article is cited by
-
PP2A-B55: substrates and regulators in the control of cellular functions
Oncogene (2022)
-
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors
Oncogene (2020)
-
Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer
Respiratory Research (2019)
-
MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
Cell Death & Disease (2015)
-
Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer
British Journal of Cancer (2014)